Specific reduction of delta-opioid receptor binding in transfected NG108-15 cells.
David K. Ann+5 more
openalex +1 more source
Genetically‐targeted control of the spinal cord and peripheral nervous system
Application of genetically‐targeted stimulation for treating diseases or injuries outside the brain. Optogenetic and chemogenetic systems have been developed for dysfunction in the cochlea, spinal cord, dorsal root ganglia (DRGs), peripheral nerves, lower urinary tract, and enteric nervous system (ENS). Created with Biorender.com.
Anakaren Romero Lozano+3 more
wiley +1 more source
Toxoplasma gondii chronic infection decreases visceral nociception through peripheral opioid receptor signaling. [PDF]
Audibert A+12 more
europepmc +1 more source
Agonist-induced, G Protein-dependent and -independent Down-regulation of the μ Opioid Receptor [PDF]
Youngshil Pak+3 more
openalex +1 more source
The mu opioid receptor: A new target for cancer therapy?
P. Singleton+4 more
semanticscholar +1 more source
The κ-opioid receptor in opioid dependence
I.K. Ho, B.K. Tsang, W. Wongchanapai
openaire +2 more sources
ABSTRACT Black Americans with disabilities experience a range of inequities including barriers to access, social stigmatization, and health outcomes that are greater than both their White and their nondisabled peers. This conceptual article explains in detail these inequities. The authors provide an overview of the existing models of disability used in
Aaron Albright+2 more
wiley +1 more source
Developing predictive models for µ opioid receptor binding using machine learning and deep learning techniques. [PDF]
Liu J+7 more
europepmc +1 more source
The Absence of a Direct Correlation between the Loss of [d-Ala2,MePhe4,Gly5-ol]Enkephalin Inhibition of Adenylyl Cyclase Activity and Agonist-induced μ-Opioid Receptor Phosphorylation [PDF]
Rachid El Kouhen+3 more
openalex +1 more source